# MEDI5752 in Japanese Patients With Advanced Solid Tumors.

> **NCT05685472** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** MEDI5752

## Key facts

- **NCT ID:** NCT05685472
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-08
- **Primary completion:** 2023-08-08
- **Final completion:** 2025-07-29
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05685472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05685472, "MEDI5752 in Japanese Patients With Advanced Solid Tumors.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05685472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*